Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond
Cancers · 30.01.2024 · 16 (3) · 579
DOI: 10.3390/cancers16030579 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.01.2024. Verfasst von Virginia Valentini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 233 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Fondazione AIRC (Associazione Italiana Ricerca sul Cancro).
Abstract (Originalsprache)
Among neoplastic diseases, breast cancer (BC) is one of the most influenced by gender. Despite common misconceptions associating BC as a women-only disease, BC can also occur in men. Additionally, transgender individuals may also experience BC. Genetic risk factors play a relevant role in BC predisposition, with important implications in precision prevention and treatment. The genetic architecture of BC susceptibility is similar in women and men, with high-, moderate-, and low-penetrance risk variants; however, some sex-specific features have emerged. Inherited high-penetrance pathogenic variants (PVs) in BRCA1 and BRCA2 genes are the strongest BC genetic risk factor. BRCA1 and BRCA2 PVs are more commonly associated with increased risk of female and male BC, respectively. Notably, BRCA-associated BCs are characterized by sex-specific pathologic features. Recently, next-generation sequencing technologies have helped to provide more insights on the role of moderate-penetrance BC risk variants, particularly in PALB2, CHEK2, and ATM genes, while international collaborative genome-wide association studies have contributed evidence on common low-penetrance BC risk variants, on their combined effect in polygenic models, and on their role as risk modulators in BRCA1/2 PV carriers. Overall, all these studies suggested that the genetic basis of male BC, although similar, may differ from female BC. Evaluating the genetic component of male BC as a distinct entity from female BC is the first step to improve both personalized risk assessment and therapeutic choices of patients of both sexes in order to reach gender equality in BC care. In this review, we summarize the latest research in the field of BC genetic predisposition with a particular focus on similarities and differences in male and female BC, and we also discuss the implications, challenges, and open issues that surround the establishment of a gender-oriented clinical management for BC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
- Medical Oncology Unit, Sant'Andrea University Hospital, 00189 Rome, Italy.
ORCID-Profile: Virginia Valentini, Agostino Bucalo, Giulia Conti, Ludovica Celli, Carlo Capalbo, Valentina Silvestri, Laura Ottini
Förderung
- Italian Association for Cancer Research
- Fondazione AIRC (Associazione Italiana Ricerca sul Cancro)
Zitieren
APA
Valentini, V., Bucalo, A., Conti, G., Celli, L., Porzio, V., Capalbo, C., Silvestri, V., & Ottini, L. (2024). Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond. Cancers, 16(3), 579. https://doi.org/10.3390/cancers16030579
Vancouver
Valentini V, Bucalo A, Conti G, Celli L, Porzio V, Capalbo C, et al. Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond. Cancers. 2024;16(3):579. doi:10.3390/cancers16030579
BibTeX
@article{Valentini2024,
author = {Valentini, Virginia and Bucalo, Agostino and Conti, Giulia and Celli, Ludovica and Porzio, Virginia and Capalbo, Carlo and Silvestri, Valentina and Ottini, Laura},
title = {Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond},
journal = {Cancers},
year = {2024},
volume = {16},
number = {3},
pages = {579},
doi = {10.3390/cancers16030579}
}
EUVIMED